These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 35936736)

  • 21. Long non-coding RNA FAM83A antisense RNA 1 (lncRNA FAM83A-AS1) targets microRNA-141-3p to regulate lung adenocarcinoma cell proliferation, migration, invasion, and epithelial-mesenchymal transition progression.
    Huang H; Yang C; Zhang Q; Zhuo T; Li X; Li N; Zhu L; Luo C; Gan J; Wu Y
    Bioengineered; 2022 Mar; 13(3):4964-4977. PubMed ID: 35164653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cuproptosis-related LncRNAs are potential prognostic and immune response markers for patients with HNSCC via the integration of bioinformatics analysis and experimental validation.
    Zhou L; Cheng Q; Hu Y; Tan H; Li X; Wu S; Zhou T; Zhou J
    Front Oncol; 2022; 12():1030802. PubMed ID: 36620545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Definition of a Novel Cuproptosis-Relevant lncRNA Signature for Uncovering Distinct Survival, Genomic Alterations, and Treatment Implications in Lung Adenocarcinoma.
    Wang Z; Yao J; Dong T; Niu X
    J Immunol Res; 2022; 2022():2756611. PubMed ID: 36281357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic Value of lncRNA DRAIC and miR-3940-3p in Lung Adenocarcinoma and Their Effect on Lung Adenocarcinoma Cell Progression.
    Liu Z; Yang S; Zhou S; Dong S; Du J
    Cancer Manag Res; 2021; 13():8367-8376. PubMed ID: 34764698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cuproptosis-Related lncRNAs are Biomarkers of Prognosis and Immune Microenvironment in Head and Neck Squamous Cell Carcinoma.
    Yang L; Yu J; Tao L; Huang H; Gao Y; Yao J; Liu Z
    Front Genet; 2022; 13():947551. PubMed ID: 35938003
    [No Abstract]   [Full Text] [Related]  

  • 26. A novel cuproptosis-related prognostic 2-lncRNAs signature in breast cancer.
    Xu QT; Wang ZW; Cai MY; Wei JF; Ding Q
    Front Pharmacol; 2022; 13():1115608. PubMed ID: 36699089
    [No Abstract]   [Full Text] [Related]  

  • 27. Cuproptosis-related lncRNAs as potential biomarkers of AML prognosis and the role of lncRNA HAGLR/miR-326/CDKN2A regulatory axis in AML.
    Du A; Yang Q; Luo X
    Am J Cancer Res; 2023; 13(9):3921-3940. PubMed ID: 37818049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prognostic value and immune landscape of a cuproptosis-related lncRNA signature in head and neck squamous cell carcinoma.
    Li YJ; Li HY; Zhang Q; Wei SL
    Front Genet; 2022; 13():942785. PubMed ID: 35942287
    [No Abstract]   [Full Text] [Related]  

  • 29. Bioinformatics construction and experimental validation of a cuproptosis-related lncRNA prognostic model in lung adenocarcinoma for immunotherapy response prediction.
    Li L; Cai Q; Wu Z; Li X; Zhou W; Lu L; Yi B; Chang R; Zhang H; Cheng Y; Zhang C; Zhang J
    Sci Rep; 2023 Feb; 13(1):2455. PubMed ID: 36774446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Construction and validation of a cuproptosis-related lncRNA signature for the prediction of the prognosis of LUAD and LUSC.
    Wang Y; Xiao X; Li Y
    Sci Rep; 2023 Feb; 13(1):2477. PubMed ID: 36774418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cuproptosis-related long non-coding RNAs model that effectively predicts prognosis in hepatocellular carcinoma.
    Huang EM; Ma N; Ma T; Zhou JY; Yang WS; Liu CX; Hou ZH; Chen S; Zong Z; Zeng B; Li YR; Zhou TC
    World J Gastrointest Oncol; 2022 Oct; 14(10):1981-2003. PubMed ID: 36310708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cuproptosis-Related lncRNA Predict Prognosis and Immune Response of LUAD.
    Zhou Q; Liu Y; Gao Y; Quan L; Wang L; Wang H
    Pharmgenomics Pers Med; 2024; 17():319-336. PubMed ID: 38952778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cuproptosis-related gene signature correlates with the tumor immune features and predicts the prognosis of early-stage lung adenocarcinoma patients.
    Tang Y; Li Q; Zhang D; Ma Z; Yang J; Cui Y; Zhang A
    Front Genet; 2022; 13():977156. PubMed ID: 36186452
    [No Abstract]   [Full Text] [Related]  

  • 34. Integrated Dissection of lncRNA-miRNA-mRNA Pairs and Potential Regulatory Role of lncRNA PCAT19 in Lung Adenocarcinoma.
    Tang X; Hua X; Peng X; Pei Y; Chen Z
    Front Genet; 2021; 12():765275. PubMed ID: 35095999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long Noncoding RNA SBF2-AS1 Is Critical for Tumorigenesis of Early-Stage Lung Adenocarcinoma.
    Chen R; Xia W; Wang S; Xu Y; Ma Z; Xu W; Zhang E; Wang J; Fang T; Zhang Q; Dong G; Cho WC; Ma PC; Brandi G; Tavolari S; Ujhazy P; Metro G; Popper HH; Yin R; Qiu M; Xu L
    Mol Ther Nucleic Acids; 2019 Jun; 16():543-553. PubMed ID: 31071530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationships of N6-Methyladenosine-Related Long Non-Coding RNAs With Tumor Immune Microenvironment and Clinical Prognosis in Lung Adenocarcinoma.
    Zhao J; Lin X; Zhuang J; He F
    Front Genet; 2021; 12():714697. PubMed ID: 34777460
    [No Abstract]   [Full Text] [Related]  

  • 37. Radiosensitization-Related Cuproptosis LncRNA Signature in Non-Small Cell Lung Cancer.
    Xu Q; Liu T; Wang J
    Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36360316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel risk model based on cuproptosis-related lncRNAs predicted prognosis and indicated immune microenvironment landscape of patients with cutaneous melanoma.
    Zhou Y; Shu Q; Fu Z; Wang C; Gu J; Li J; Chen Y; Xie M
    Front Genet; 2022; 13():959456. PubMed ID: 35938036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of cuproptosis-related gene in lung adenocarcinoma.
    Liu Y; Lin W; Yang Y; Shao J; Zhao H; Wang G; Shen A
    Front Oncol; 2022; 12():1080985. PubMed ID: 36620594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cuproptosis-related ceRNA axis triggers cell proliferation and cell cycle through CBX2 in lung adenocarcinoma.
    Wu J; Fu G; Luo C; Chen L; Liu Q
    BMC Pulm Med; 2024 Feb; 24(1):85. PubMed ID: 38355480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.